A Phase 1 Dose Escalation Study of IPI-493
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Biogen